Table 4:
SpO2 Cutoff | Sensitivity (95% CI) |
Specificity (95% CI) |
NPV (95% CI) |
PPV (95% CI) |
---|---|---|---|---|
< 96% | 0.28 (0.18 – 0.38) | 0.84 (0.80 – 0.89) | 0.82 (0.77 – 0.86) | 0.32 (0.21 – 0.43) |
≤ 94% | 0.21 (0.12 – 0.31) | 0.93 (0.90 – 0.96) | 0.82 (0.78 – 0.86) | 0.44 (0.28 – 0.61) |
≤ 97% (Optimal) | 0.56 (0.45 – 0.67) | 0.57 (0.51 – 0.63) | 0.83 (0.78 – 0.88) | 0.25 (0.19 – 0.32) |
Cohort | Sensitivity (95% CI) |
Specificity (95% CI) |
NPV (95% CI) |
PPV (95% CI) |
---|---|---|---|---|
< 96% | 0.28 (0.18 – 0.38) | 0.91 (0.86 – 0.96) | 0.68 (0.61 – 0.75) | 0.66 (0.49 – 0.82) |
≤ 94% | 0.21 (0.12 – 0.31) | 0.96 (0.93 – 0.99) | 0.67 (0.61 – 0.74) | 0.76 (0.58 – 0.94) |
≤ 97% (Optimal) | 0.56 (0.45 – 0.67) | 0.68 (0.60 – 0.76) | 0.72 (0.64 – 0.80) | 0.51 (0.40 – 0.61) |
Cohort | Sensitivity (95% CI) |
Specificity (95% CI) |
NPV (95% CI) |
PPV (95% CI) |
---|---|---|---|---|
< 96% | 0.71 (0.38 – 1.00) | 0.83 (0.79 – 0.87) | 0.99 (0.98 – 1.00) | 0.08 (0.01 – 0.14) |
≤ 94% | 0.71 (0.38 – 1.00) | 0.91 (0.88 – 0.94) | 0.99 (0.98 – 1.00) | 0.14 (0.03 – 0.25) |
≤ 88% (Optimal) | 0.71 (0.38 – 1.00) | 0.99 (0.98 – 1.00) | 0.99 (0.99 – 1.00) | 0.62 (0.29 – 0.96) |